The Medical Mattresses segmentation by Type distinguishes four technology-driven clusters that collectively shape demand elasticity and ASP erosion. Foam-based surfaces (polyurethane, memory, gel-infused) dominate volumes, capturing 42 % of 2023 global units, driven by low replacement friction and compatibility with home-care frames. Innerspring variants, though losing share, retain 21 % owing to superior airflow in acute wards with limited HVAC capacity. Air therapy mattresses contribute 18 % of revenue but only 7 % of units, commanding a 5-6× ASP premium by mitigating stage-III/IV pressure injuries, thereby lowering hospital readmission penalties. Hybrid cores (foam + micro-coil + air bladders) are the fastest-expanding niche, growing 9 % CAGR, as they reconcile clinical efficacy with reimbursement caps in North American LTAC facilities. Each subtype’s reimbursement code (HCPCS E0186, E0193) anchors pricing corridors, making taxonomy selection a direct input to revenue forecasting.